HEPATITIS B INITIATIVE OF WASHINGTON DC (EIN 205841637) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Phone

5712203195

Tax Period

2024-01-01 to 2024-12-31

HEPATITIS B INITIATIVE OF WASHINGTON DC, founded in 2006, is a community nonprofit in the Health Care sector that reported $1.6M in total revenue in fiscal year 2024. Revenue surged 43% from the prior year, signaling strong growth momentum. Expenses of $1.8M exceeded revenue, resulting in a 14% operating deficit.

Mission

Prevention of liver diseases caused by viral hepatitis through collaborative partnerships, culturally and linguistically appropriate viral hepatitis outreach, education, screening, vaccination and linkage to care and patient navigation services for impacted communities.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,598,951

Program Service Revenue $0

Investment Income $16,089

Other Revenue $0

TOTAL REVENUE $1,615,040

Expense Breakdown

Grants Paid $0

Salaries & Benefits $974,217

Fundraising Expenses $0

Program Expenses $1,541,879

Other Expenses $873,910

TOTAL EXPENSES $1,848,127

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,615,040	$1,133,289	+0.4%
Expenses	$1,848,127	$1,187,026	+0.6%
Net Income	$-233,087	$-53,737	+3.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$100,625

Total Directors

$100,625

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SANDRA ASHFORD	CEO	40.00	Officer Director	$100,625	$0	$100,625
MICHAEL P REYES	Chairman	0.00	Director	$0	$0	$0
DR LYDIA TANG MD	Director	0.00	Director	$0	$0	$0
RONA JOBE	Secretary	0.00	Director	$0	$0	$0
PETROS TADESSE	Director	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,615,040	$1,848,127	$314,029	$-233,087
2023	$1,133,289	$1,187,026	$633,271	$-53,737
2022	$1,132,859	$1,030,175	$684,914	$102,684
2021	$988,619	$805,281	$543,864	$183,338
2020	$384,341	$411,450	$331,646	$-27,109
2019	$484,776	$332,067	$368,902	$152,709
2018	$515,055	$386,912	$257,662	$128,143

HEPATITIS B INITIATIVE OF WASHINGTON DC